- JP-listed companies
- Kubota Pharmaceutical Holdings Co., Ltd.
- Financials
- Return on equity (%)
Kubota Pharmaceutical Holdings Co., Ltd. (4596)
Market cap
¥11.2B
P/E ratio
Kubota Pharmaceutical develops innovative eye disease treatments including wearable myopia devices and pharmaceuticals for conditions like diabetic retinopathy.
| Period End | Return on equity (%) (Million JPY) | YoY (%) |
|---|---|---|
| Dec 31, 2025 | -42.2 | -36.07% |
| Dec 31, 2024 | -66 | +46.20% |
| Dec 31, 2023 | -45.2 | -9.22% |
| Dec 31, 2022 | -49.8 | -3.53% |
| Dec 31, 2021 | -51.6 | +48.86% |
| Dec 31, 2020 | -34.6 | -50.97% |
| Dec 31, 2019 | -70.7 | -93.45% |
| Dec 31, 2018 | -1,078.5 | +2480.86% |
| Dec 31, 2017 | -41.8 | -12.66% |
| Dec 31, 2016 | -47.8 |